To elucidate the effects of Olaparib on GBM cells and its potential to potentiate NK cell-mediated responses in the GBM microenvironment, we first assessed changes in NKR ligand expression on the surface of the GBM cell line T98G cells in response to PARP inhibition. Here, PARP1 is linked to glioblastoma.